{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:37:02Z","timestamp":1793194622806,"version":"4.5.0"},"reference-count":145,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1038\/s41582-026-01263-2","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T13:26:08Z","timestamp":1788787568000},"page":"667-681","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cortical lesions in multiple sclerosis: 25 years of progress, remaining challenges and future directions"],"prefix":"10.1038","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3362-7403","authenticated-orcid":false,"given":"Massimiliano","family":"Calabrese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Magliozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9972-4348","authenticated-orcid":false,"given":"Agnese","family":"Tamanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0426-7223","authenticated-orcid":false,"given":"Stefano","family":"Ziccardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8654-5360","authenticated-orcid":false,"given":"Chiara","family":"Eccher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Biasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca Benedetta","family":"Pizzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0358-9431","authenticated-orcid":false,"given":"Damiano","family":"Marastoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,7]]},"reference":[{"key":"1263_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/brain\/122.1.17","volume":"122","author":"D Kidd","year":"1999","unstructured":"Kidd, D. et al. Cortical lesions in multiple sclerosis. Brain 122, 17\u201326 (1999).","journal-title":"Brain"},{"key":"1263_CR2","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/ana.1123","volume":"50","author":"JW Peterson","year":"2001","unstructured":"Peterson, J. W., B\u00f6, L., M\u00f6rk, S., Chang, A. & Trapp, B. D. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann. Neurol. 50, 389\u2013400 (2001).","journal-title":"Ann. Neurol."},{"key":"1263_CR3","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1093\/brain\/awm038","volume":"130","author":"R Magliozzi","year":"2007","unstructured":"Magliozzi, R. et al. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 130, 1089\u20131104 (2007).","journal-title":"Brain"},{"key":"1263_CR4","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1056\/NEJMoa1100648","volume":"365","author":"CF Lucchinetti","year":"2011","unstructured":"Lucchinetti, C. F. et al. Inflammatory cortical demyelination in early multiple sclerosis. N. Engl. J. Med. 365, 2188\u20132197 (2011). Lucchinetti et al. demonstrated that extensive inflammatory cortical demyelination is already present in the early stages of MS, providing pivotal neuropathological evidence that grey matter involvement is an early and integral component of the disease pathology rather than a late degenerative phenomenon.","journal-title":"N. Engl. J. Med."},{"key":"1263_CR5","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.neuron.2024.11.016","volume":"113","author":"W Macnair","year":"2025","unstructured":"Macnair, W. et al. snRNA-seq stratifies multiple sclerosis patients into distinct white matter glial responses. Neuron 113, 396\u2013410.e9 (2025).","journal-title":"Neuron"},{"key":"1263_CR6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41586-019-1404-z","volume":"573","author":"L Schirmer","year":"2019","unstructured":"Schirmer, L. et al. Neuronal vulnerability and multilineage diversity in multiple sclerosis. Nature 573, 75\u201382 (2019).","journal-title":"Nature"},{"key":"1263_CR7","first-page":"572","volume":"26","author":"JJG Geurts","year":"2005","unstructured":"Geurts, J. J. G. et al. Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. AJNR Am. J. Neuroradiol. 26, 572\u2013577 (2005). Through combined post-mortem MRI and histopathology, Geurts et al. provided compelling evidence that conventional MRI markedly underestimates cortical lesion burden in MS.","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"1263_CR8","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1001\/archneur.64.10.1416","volume":"64","author":"M Calabrese","year":"2007","unstructured":"Calabrese, M. et al. Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis. Arch. Neurol. 64, 1416\u20131422 (2007). A large-scale MRI study demonstrating that cortical lesions are a frequent phenomenon in MS, already detectable in the early phases of the disease, using double inversion recovery imaging.","journal-title":"Arch. Neurol."},{"key":"1263_CR9","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1212\/WNL.0b013e31820a0cc4","volume":"76","author":"JJG Geurts","year":"2011","unstructured":"Geurts, J. J. G. et al. Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI. Neurology 76, 418\u2013424 (2011). Geurts et al. established consensus recommendations for the identification and scoring of cortical lesions in MS using double inversion recovery MRI, providing a standardized framework to improve reproducibility and comparability across studies.","journal-title":"Neurology"},{"key":"1263_CR10","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1136\/jnnp-2015-311102","volume":"87","author":"V Sethi","year":"2016","unstructured":"Sethi, V. et al. A longitudinal study of cortical grey matter lesion subtypes in relapse-onset multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 87, 750\u2013753 (2016).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1263_CR11","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1212\/WNL.0b013e3182a08ce8","volume":"81","author":"AS Nielsen","year":"2013","unstructured":"Nielsen, A. S. et al. Contribution of cortical lesion subtypes at 7T MRI to physical and cognitive performance in MS. Neurology 81, 641\u2013649 (2013).","journal-title":"Neurology"},{"key":"1263_CR12","doi-asserted-by":"publisher","first-page":"791","DOI":"10.3174\/ajnr.A3289","volume":"34","author":"ID Kilsdonk","year":"2013","unstructured":"Kilsdonk, I. D. et al. Multicontrast MR imaging at 7T in multiple sclerosis: Highest lesion detection in cortical gray matter with 3D-FLAIR. Am. J. Neuroradiol. 34, 791\u2013796 (2013).","journal-title":"Am. J. Neuroradiol."},{"key":"1263_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcae158","volume":"6","author":"ES Beck","year":"2024","unstructured":"Beck, E. S. et al. Contribution of new and chronic cortical lesions to disability accrual in multiple sclerosis. Brain Commun. 6, fcae158 (2024).","journal-title":"Brain Commun."},{"key":"1263_CR14","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200399","volume":"12","author":"D Marastoni","year":"2025","unstructured":"Marastoni, D. et al. Intrathecal inflammatory profile and gray matter damage predict progression independent of relapse activity in early multiple sclerosis. Neurol. Neuroimmunol. Neuroinflamm. 12, e200399 (2025). The 2025 study showed that intrathecal inflammatory profiles combined with grey matter damage predict early progression independent of relapse activity, providing insights into the biological substrate of progression independent of relapse activity in MS.","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"1263_CR15","doi-asserted-by":"publisher","first-page":"557","DOI":"10.3174\/ajnr.A8983","volume":"47","author":"E Barbuti","year":"2026","unstructured":"Barbuti, E. et al. Choroid plexus enlargement in multiple sclerosis correlates with cortical and phase rim lesions on 7-T MRI and predicts progression independent of relapse activity. AJNR Am. J. Neuroradiol. 47, 557\u2013565 (2026).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"1263_CR16","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1001\/jamaneurol.2022.4655","volume":"80","author":"C Tur","year":"2023","unstructured":"Tur, C. et al. Association of early progression independent of relapse activity with long-term disability after a first demyelinating event in multiple sclerosis. JAMA Neurol. 80, 151\u2013160 (2023).","journal-title":"JAMA Neurol."},{"key":"1263_CR17","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1111\/ene.15697","volume":"30","author":"S Ziccardi","year":"2023","unstructured":"Ziccardi, S. et al. Cortical lesions at diagnosis predict long-term cognitive impairment in multiple sclerosis: A 20-year study. Eur. J. Neurol. 30, 1378\u20131388 (2023). Ziccardi et al. demonstrated that cortical lesions detected at diagnosis independently predict long-term cognitive impairment over 20 years of follow-up in MS.","journal-title":"Eur. J. Neurol."},{"key":"1263_CR18","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1097\/NEN.0000000000000189","volume":"74","author":"R Klaver","year":"2015","unstructured":"Klaver, R. et al. Neuronal and axonal loss in normal-appearing gray matter and subpial lesions in multiple sclerosis. J. Neuropathol. Exp. Neurol. 74, 453\u2013458 (2015).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"1263_CR19","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1093\/brain\/awh641","volume":"128","author":"A Kutzelnigg","year":"2005","unstructured":"Kutzelnigg, A. et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 128, 2705\u20132712 (2005).","journal-title":"Brain"},{"key":"1263_CR20","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/j.1600-0404.2006.00615.x","volume":"183","author":"L B\u00f6","year":"2006","unstructured":"B\u00f6, L., Geurts, J. J. G., M\u00f6rk, S. J. & Van Der Valk, P. Grey matter pathology in multiple sclerosis. Acta Neurol. Scand. Suppl. 183, 48\u201350 (2006).","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"1263_CR21","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1093\/brain\/awr182","volume":"134","author":"OW Howell","year":"2011","unstructured":"Howell, O. W. et al. Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis. Brain 134, 2755\u20132771 (2011).","journal-title":"Brain"},{"key":"1263_CR22","first-page":"51","volume":"7","author":"L Griffiths","year":"2020","unstructured":"Griffiths, L. et al. Substantial subpial cortical demyelination in progressive multiple sclerosis: have we underestimated the extent of cortical pathology? Neuroimmunol. Neuroinflamm. 7, 51\u201367 (2020).","journal-title":"Neuroimmunol. Neuroinflamm."},{"key":"1263_CR23","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1097\/NEN.0b013e3181b4bf8f","volume":"68","author":"E-J Kooi","year":"2009","unstructured":"Kooi, E.-J., Geurts, J. J. G., van Horssen, J., B\u00f8, L. & van der Valk, P. Meningeal Inflammation is not Associated With Cortical Demyelination in Chronic Multiple Sclerosis. J. Neuropathol. Exp. Neurol. 68, 1021\u20131028 (2009).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"1263_CR24","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1002\/ana.22230","volume":"68","author":"R Magliozzi","year":"2010","unstructured":"Magliozzi, R. et al. A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis. Ann. Neurol. 68, 477\u2013493 (2010). Seminal paper showing that meningeal inflammatory infiltrates are associated with a gradient of neuronal loss extending from the pial surface into the cortex, supporting a causal link between chronic meningeal inflammation and cortical neurodegeneration in MS.","journal-title":"Ann. Neurol."},{"key":"1263_CR25","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1212\/WNL.0000000000001586","volume":"85","author":"C Mainero","year":"2015","unstructured":"Mainero, C. & Louapre, C. Meningeal inflammation in multiple sclerosis: the key to the origin of cortical lesions? Neurology 85, 12\u201313 (2015).","journal-title":"Neurology"},{"key":"1263_CR26","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/ana.25429","volume":"85","author":"G Fadda","year":"2019","unstructured":"Fadda, G. et al. A surface-in gradient of thalamic damage evolves in pediatric multiple sclerosis. Ann. Neurol. 85, 340\u2013351 (2019).","journal-title":"Ann. Neurol."},{"key":"1263_CR27","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1093\/brain\/awaa379","volume":"144","author":"E De Meo","year":"2021","unstructured":"De Meo, E. et al. In vivo gradients of thalamic damage in paediatric multiple sclerosis: a window into pathology. Brain 144, 186\u2013197 (2021).","journal-title":"Brain"},{"key":"1263_CR28","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1002\/ana.24461","volume":"78","author":"M Jehna","year":"2015","unstructured":"Jehna, M. et al. Periventricular lesions correlate with cortical thinning in multiple sclerosis. Ann. Neurol. 78, 530\u2013539 (2015).","journal-title":"Ann. Neurol."},{"key":"1263_CR29","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1002\/ana.26448","volume":"92","author":"R Magliozzi","year":"2022","unstructured":"Magliozzi, R. et al. \u2018Ependymal-in\u2019 gradient of thalamic damage in progressive multiple sclerosis. Ann. Neurol. 92, 670\u2013685 (2022).","journal-title":"Ann. Neurol."},{"key":"1263_CR30","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1177\/1352458515579445","volume":"22","author":"R Nicholas","year":"2016","unstructured":"Nicholas, R., Magliozzi, R., Campbell, G., Mahad, D. & Reynolds, R. Temporal lobe cortical pathology and inhibitory GABA interneuron cell loss are associated with seizures in multiple sclerosis. Mult. Scler. 22, 25\u201335 (2016).","journal-title":"Mult. Scler."},{"key":"1263_CR31","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/NEN.0b013e31827bfc62","volume":"72","author":"R Magliozzi","year":"2013","unstructured":"Magliozzi, R. et al. B-cell enrichment and Epstein-Barr virus infection in inflammatory cortical lesions in secondary progressive multiple sclerosis. J. Neuropathol. Exp. Neurol. 72, 29\u201341 (2013).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"1263_CR32","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1093\/brain\/awab025","volume":"144","author":"M Pardini","year":"2021","unstructured":"Pardini, M., Brown, J. W. L., Magliozzi, R., Reynolds, R. & Chard, D. T. Surface-in pathology in multiple sclerosis: a new view on pathogenesis? Brain 144, 1646\u20131654 (2021).","journal-title":"Brain"},{"key":"1263_CR33","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adx2652","volume":"17","author":"J Shin","year":"2025","unstructured":"Shin, J. et al. Bruton\u2019s tyrosine kinase inhibitors rescue neuronal impairment caused by B cell\u2013mediated lymphotoxin-\u03b1 release. Sci. Transl. Med. 17, eadx2652 (2025).","journal-title":"Sci. Transl. Med."},{"key":"1263_CR34","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41590-025-02359-5","volume":"27","author":"I Naouar","year":"2026","unstructured":"Naouar, I. et al. Lymphotoxin-dependent elevated meningeal CXCL13:BAFF ratios drive gray matter injury. Nat. Immunol. 27, 48\u201360 (2026).","journal-title":"Nat. Immunol."},{"key":"1263_CR35","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/s41593-022-01097-3","volume":"25","author":"M Kaufmann","year":"2022","unstructured":"Kaufmann, M. et al. Identification of early neurodegenerative pathways in progressive multiple sclerosis. Nat. Neurosci. 25, 944\u2013955 (2022).","journal-title":"Nat. Neurosci."},{"key":"1263_CR36","doi-asserted-by":"publisher","first-page":"e2107","DOI":"10.1212\/WNL.0000000000005685","volume":"90","author":"A Scalfari","year":"2018","unstructured":"Scalfari, A. et al. The cortical damage, early relapses, and onset of the progressive phase in multiple sclerosis. Neurology 90, e2107\u2013e2118 (2018). Robust evidence in a large cohort with long-term follow-up, which shows cortical damage is associated with a more aggressive disease course and an earlier transition to the progressive phase of MS.","journal-title":"Neurology"},{"key":"1263_CR37","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1093\/brain\/awab033","volume":"144","author":"L Haider","year":"2021","unstructured":"Haider, L. et al. Cortical involvement determines impairment 30 years after a clinically isolated syndrome. Brain 144, 1384\u20131395 (2021). Haider et al. demonstrated, in a uniquely long-term longitudinal study, that cortical involvement is a major determinant of physical and cognitive impairment 30 years after a clinically isolated syndrome.","journal-title":"Brain"},{"key":"1263_CR38","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.ade8560","volume":"16","author":"CC Gross","year":"2024","unstructured":"Gross, C. C. et al. Multiple sclerosis endophenotypes identified by high-dimensional blood signatures are associated with distinct disease trajectories. Sci. Transl. Med. 16, eade8560 (2024).","journal-title":"Sci. Transl. Med."},{"key":"1263_CR39","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/S1474-4422(22)00471-9","volume":"22","author":"F Aloisi","year":"2023","unstructured":"Aloisi, F., Giovannoni, G. & Salvetti, M. Epstein-Barr virus as a cause of multiple sclerosis: opportunities for prevention and therapy. Lancet Neurol. 22, 338\u2013349 (2023).","journal-title":"Lancet Neurol."},{"key":"1263_CR40","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1126\/science.abj8222","volume":"375","author":"K Bjornevik","year":"2022","unstructured":"Bjornevik, K. et al. Longitudinal analysis reveals high prevalence of epstein-barr virus associated with multiple sclerosis. Science 375, 296\u2013301 (2022).","journal-title":"Science"},{"key":"1263_CR41","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1177\/1073858410381531","volume":"17","author":"MP Pender","year":"2011","unstructured":"Pender, M. P. The Essential Role of Epstein\u2013Barr virus in the pathogenesis of multiple sclerosis. Neuroscientist 17, 351\u2013367 (2011).","journal-title":"Neuroscientist"},{"key":"1263_CR42","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/s41586-023-06250-x","volume":"619","author":"A Harroud","year":"2023","unstructured":"Harroud, A. et al. Locus for severity implicates CNS resilience in progression of multiple sclerosis. Nature 619, 323\u2013331 (2023).","journal-title":"Nature"},{"key":"1263_CR43","doi-asserted-by":"publisher","unstructured":"De Jager, P. et al. GWAS highlights the neuronal contribution to multiple sclerosis susceptibility. Preprint at Research Square https:\/\/doi.org\/10.21203\/rs.3.rs-5644532\/v1 (2025).","DOI":"10.21203\/rs.3.rs-5644532\/v1"},{"key":"1263_CR44","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1148\/radiol.2361040450","volume":"236","author":"JJG Geurts","year":"2005","unstructured":"Geurts, J. J. G. et al. Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. Radiology 236, 254\u2013260 (2005).","journal-title":"Radiology"},{"key":"1263_CR45","first-page":"2161","volume":"27","author":"F Bagnato","year":"2006","unstructured":"Bagnato, F. et al. In vivo detection of cortical plaques by MR imaging in patients with multiple sclerosis. AJNR Am. J. Neuroradiol. 27, 2161\u20132167 (2006).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"1263_CR46","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1212\/WNL.0b013e3181f5d4da","volume":"75","author":"M Calabrese","year":"2010","unstructured":"Calabrese, M. et al. Imaging distribution and frequency of cortical lesions in patients with multiple sclerosis. Neurology 75, 1234\u20131240 (2010).","journal-title":"Neurology"},{"key":"1263_CR47","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.3174\/ajnr.A0645","volume":"28","author":"F Nelson","year":"2007","unstructured":"Nelson, F. et al. Improved identification of intracortical lesions in multiple sclerosis with phase-sensitive inversion recovery in combination with fast double inversion recovery MR imaging. AJNR Am. J. Neuroradiol. 28, 1645\u20131649 (2007).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"1263_CR48","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1093\/brain\/awaa233","volume":"143","author":"PM Bouman","year":"2020","unstructured":"Bouman, P. M. et al. Histopathology-validated recommendations for cortical lesion imaging in multiple sclerosis. Brain 143, 2988\u20132997 (2020).","journal-title":"Brain"},{"key":"1263_CR49","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1177\/1352458508094644","volume":"14","author":"F Nelson","year":"2008","unstructured":"Nelson, F., Poonawalla, A., Hou, P., Wolinsky, J. S. & Narayana, P. A. 3D MPRAGE improves classification of cortical lesions in multiple sclerosis. Mult. Scler. 14, 1214\u20131219 (2008).","journal-title":"Mult. Scler."},{"key":"1263_CR50","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1212\/WNL.0b013e31824528a0","volume":"78","author":"A Seewann","year":"2012","unstructured":"Seewann, A. et al. Postmortem verification of MS cortical lesion detection with 3D DIR. Neurology 78, 302\u2013308 (2012).","journal-title":"Neurology"},{"key":"1263_CR51","doi-asserted-by":"publisher","first-page":"4586","DOI":"10.1007\/s00330-020-06803-y","volume":"30","author":"S Cocozza","year":"2020","unstructured":"Cocozza, S. et al. A clinically feasible 7-Tesla protocol for the identification of cortical lesions in Multiple Sclerosis. Eur. Radiol. 30, 4586\u20134594 (2020).","journal-title":"Eur. Radiol."},{"key":"1263_CR52","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1097\/RLI.0000000000001082","volume":"59","author":"P Durozard","year":"2024","unstructured":"Durozard, P. et al. Cortical lesions as an early hallmark of multiple sclerosis: visualization by 7 T MRI. Invest. Radiol. 59, 747\u2013753 (2024).","journal-title":"Invest. Radiol."},{"key":"1263_CR53","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1148\/radiol.2019181719","volume":"291","author":"CA Treaba","year":"2019","unstructured":"Treaba, C. A. et al. Longitudinal characterization of cortical lesion development and evolution in multiple sclerosis with 7.0-T MRI. Radiology 291, 740\u2013749 (2019). Treaba et al. provided longitudinal in vivo characterization of cortical lesion development and evolution in MS using 7\u2009T MRI, demonstrating that cortical lesions are dynamic entities with heterogeneous trajectories of expansion, stabilization and tissue damage over time.","journal-title":"Radiology"},{"key":"1263_CR54","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1002\/ana.25786","volume":"88","author":"R Magliozzi","year":"2020","unstructured":"Magliozzi, R. et al. The CSF profile linked to cortical damage predicts multiple sclerosis activity. Ann. Neurol. 88, 562\u2013573 (2020).","journal-title":"Ann. Neurol."},{"key":"1263_CR55","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1093\/brain\/aww037","volume":"139","author":"ID Kilsdonk","year":"2016","unstructured":"Kilsdonk, I. D. et al. Increased cortical grey matter lesion detection in multiple sclerosis with 7 T MRI: a post-mortem verification study. Brain 139, 1472\u20131481 (2016).","journal-title":"Brain"},{"key":"1263_CR56","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1177\/1352458511406575","volume":"17","author":"A Seewann","year":"2011","unstructured":"Seewann, A. et al. Imaging the tip of the iceberg: visualization of cortical lesions in multiple sclerosis. Mult. Scler. 17, 1202\u20131210 (2011).","journal-title":"Mult. Scler."},{"key":"1263_CR57","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1001\/jamaneurol.2015.1241","volume":"72","author":"DM Harrison","year":"2015","unstructured":"Harrison, D. M. et al. Association of cortical lesion burden on 7-T magnetic resonance imaging with cognition and disability in multiple sclerosis. JAMA Neurol. 72, 1004\u20131012 (2015).","journal-title":"JAMA Neurol."},{"key":"1263_CR58","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1007\/s00415-012-6571-x","volume":"259","author":"M Absinta","year":"2012","unstructured":"Absinta, M. et al. Patients with migraine do not have MRI-visible cortical lesions. J. Neurol. 259, 2695\u20132698 (2012).","journal-title":"J. Neurol."},{"key":"1263_CR59","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1212\/WNL.0b013e3182648bc8","volume":"79","author":"T Sinnecker","year":"2012","unstructured":"Sinnecker, T. et al. Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis. Neurology 79, 708\u2013714 (2012).","journal-title":"Neurology"},{"key":"1263_CR60","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1212\/WNL.0b013e31826e9a96","volume":"79","author":"M Calabrese","year":"2012","unstructured":"Calabrese, M. et al. No MRI evidence of cortical lesions in neuromyelitis optica. Neurology 79, 1671\u20131676 (2012).","journal-title":"Neurology"},{"key":"1263_CR61","doi-asserted-by":"publisher","first-page":"e308","DOI":"10.1212\/WNL.0000000000201465","volume":"100","author":"R Cortese","year":"2023","unstructured":"Cortese, R. et al. Differentiating multiple sclerosis from AQP4-neuromyelitis optica spectrum disorder and MOG-antibody disease with imaging. Neurology 100, e308\u2013e323 (2023).","journal-title":"Neurology"},{"key":"1263_CR62","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson, A. J. et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 17, 162\u2013173 (2018). The 2017 revision of the McDonald criteria was the first diagnostic framework to formally incorporate cortical lesions as a valid location for dissemination in space, acknowledging their established pathological and imaging relevance in MS.","journal-title":"Lancet Neurol."},{"key":"1263_CR63","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200253","volume":"11","author":"S Borrelli","year":"2024","unstructured":"Borrelli, S. et al. Central vein sign, cortical lesions, and paramagnetic rim lesions for the diagnostic and prognostic workup of multiple sclerosis. Neurol. Neuroimmunol. Neuroinflamm. 11, e200253 (2024).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"1263_CR64","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1001\/jamaneurol.2023.4737","volume":"81","author":"A Cagol","year":"2024","unstructured":"Cagol, A. et al. Diagnostic performance of cortical lesions and the central vein sign in multiple sclerosis. JAMA Neurol. 81, 143\u2013153 (2024).","journal-title":"JAMA Neurol."},{"key":"1263_CR65","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/S1474-4422(25)00304-7","volume":"24","author":"F Barkhof","year":"2025","unstructured":"Barkhof, F. et al. 2024 MAGNIMS\u2013CMSC\u2013NAIMS consensus recommendations on the use of MRI for the diagnosis of multiple sclerosis. Lancet Neurol. 24, 866\u2013879 (2025).","journal-title":"Lancet Neurol."},{"key":"1263_CR66","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.221425","volume":"307","author":"PM Bouman","year":"2023","unstructured":"Bouman, P. M. et al. Multicenter evaluation of AI-generated DIR and PSIR for cortical and juxtacortical multiple sclerosis lesion detection. Radiology 307, e221425 (2023).","journal-title":"Radiology"},{"key":"1263_CR67","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1097\/WCO.0000000000001152","volume":"36","author":"C Mainero","year":"2023","unstructured":"Mainero, C., Treaba, C. A. & Barbuti, E. Imaging cortical lesions in multiple sclerosis. Curr. Opin. Neurol. 36, 222\u2013228 (2023). A comprehensive narrative review summarizing the state of the art in cortical lesion imaging in MS, from conventional MRI to ultrahigh-field techniques.","journal-title":"Curr. Opin. Neurol."},{"key":"1263_CR68","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1212\/WNL.0b013e3181a0fee5","volume":"72","author":"M Calabrese","year":"2009","unstructured":"Calabrese, M. et al. Cortical lesions in primary progressive multiple sclerosis: a 2-year longitudinal MR study. Neurology 72, 1330\u20131336 (2009).","journal-title":"Neurology"},{"key":"1263_CR69","doi-asserted-by":"publisher","first-page":"20","DOI":"10.4161\/pri.22580","volume":"7","author":"M Calabrese","year":"2013","unstructured":"Calabrese, M., Favaretto, A., Martini, V. & Gallo, P. Grey matter lesions in MS: from histology to clinical implications. Prion 7, 20\u201327 (2013).","journal-title":"Prion"},{"key":"1263_CR70","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1177\/13524585211069167","volume":"28","author":"ES Beck","year":"2022","unstructured":"Beck, E. S. et al. Cortical lesion hotspots and association of subpial lesions with disability in multiple sclerosis. Mult. Scler. 28, 1351\u20131363 (2022).","journal-title":"Mult. Scler."},{"key":"1263_CR71","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1177\/1352458509106510","volume":"15","author":"M Calabrese","year":"2009","unstructured":"Calabrese, M. & Gallo, P. Magnetic resonance evidence of cortical onset of multiple sclerosis. Mult. Scler. 15, 933\u2013941 (2009).","journal-title":"Mult. Scler."},{"key":"1263_CR72","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1212\/WNL.0b013e318238ee9b","volume":"77","author":"A Giorgio","year":"2011","unstructured":"Giorgio, A. et al. Cortical lesions in radiologically isolated syndrome. Neurology 77, 1896\u20131899 (2011).","journal-title":"Neurology"},{"key":"1263_CR73","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1212\/WNL.0b013e31820f2e69","volume":"76","author":"M Absinta","year":"2011","unstructured":"Absinta, M. et al. Cortical lesions in children with multiple sclerosis. Neurology 76, 910\u2013913 (2011).","journal-title":"Neurology"},{"key":"1263_CR74","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/S1474-4422(12)70230-2","volume":"11","author":"JJ Geurts","year":"2012","unstructured":"Geurts, J. J., Calabrese, M., Fisher, E. & Rudick, R. A. Measurement and clinical effect of grey matter pathology in multiple sclerosis. Lancet Neurol. 11, 1082\u20131092 (2012).","journal-title":"Lancet Neurol."},{"key":"1263_CR75","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1177\/135245859600100405","volume":"1","author":"L Truyen","year":"1996","unstructured":"Truyen, L. et al. Magnetic resonance imaging of epilepsy in multiple sclerosis: a case control study. Implications for treatment trials with 4-aminopyridine. Mult. Scler. 1, 213\u2013217 (1996).","journal-title":"Mult. Scler."},{"key":"1263_CR76","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1136\/jnnp-2011-300414","volume":"83","author":"M Calabrese","year":"2012","unstructured":"Calabrese, M. et al. Cortical pathology in multiple sclerosis patients with epilepsy: a 3 year longitudinal study. J. Neurol. Neurosurg. Psychiatry 83, 49\u201354 (2012). Longitudinal evidence that cortical pathology and cortical lesion accumulation are more pronounced in people with MS with epilepsy than those without epilepsy, supporting a pathogenic link between cortical damage and seizure susceptibility.","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1263_CR77","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00415-008-0752-7","volume":"255","author":"M Calabrese","year":"2008","unstructured":"Calabrese, M. et al. Extensive cortical inflammation is associated with epilepsy in multiple sclerosis. J. Neurol. 255, 581\u2013586 (2008).","journal-title":"J. Neurol."},{"key":"1263_CR78","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1111\/ene.15405","volume":"29","author":"D Ciolac","year":"2022","unstructured":"Ciolac, D. et al. Altered grey matter integrity and network vulnerability relate to epilepsy occurrence in patients with multiple sclerosis. Eur. J. Neurol. 29, 2309\u20132320 (2022).","journal-title":"Eur. J. Neurol."},{"key":"1263_CR79","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1177\/1352458516651502","volume":"23","author":"M Calabrese","year":"2017","unstructured":"Calabrese, M. et al. Epilepsy in multiple sclerosis: the role of temporal lobe damage. Mult. Scler. 23, 473\u2013482 (2017).","journal-title":"Mult. Scler."},{"key":"1263_CR80","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000213650","volume":"104","author":"EA Krijnen","year":"2025","unstructured":"Krijnen, E. A. et al. Evolution of Cortical Lesions and Function-Specific cognitive decline in people with multiple sclerosis. Neurology 104, e213650 (2025).","journal-title":"Neurology"},{"key":"1263_CR81","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1001\/archneurol.2009.174","volume":"66","author":"M Calabrese","year":"2009","unstructured":"Calabrese, M. et al. Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. Arch. Neurol. 66, 1144\u20131150 (2009).","journal-title":"Arch. Neurol."},{"key":"1263_CR82","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/acn3.52261","volume":"12","author":"EA Krijnen","year":"2025","unstructured":"Krijnen, E. A., Jonkman, L. E., Steenwijk, M. D. & Van der Voort, S. R. Cortical lesions impact cognitive decline in multiple sclerosis via volume loss of nonlesional cortex. Ann. Clin. Trans. Neurol. 12, 121\u2013136 (2025).","journal-title":"Ann. Clin. Trans. Neurol."},{"key":"1263_CR83","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1177\/13524585241260968","volume":"30","author":"EA Krijnen","year":"2024","unstructured":"Krijnen, E. A. et al. Subtypes and location of (juxta)cortical lesions relate to cognitive dysfunction in people with multiple sclerosis. Mult. Scler. 30, 1556\u20131560 (2024).","journal-title":"Mult. Scler."},{"key":"1263_CR84","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1007\/s10072-025-08141-7","volume":"46","author":"JS Lee","year":"2025","unstructured":"Lee, J. S., Wagshul, M. E., Nayak, S. & Holtzer, R. Presence of cortical lesions in older persons with multiple sclerosis and association with cognitive function. Neurol. Sci. 46, 3165\u20133173 (2025).","journal-title":"Neurol. Sci."},{"key":"1263_CR85","doi-asserted-by":"publisher","first-page":"1290666","DOI":"10.3389\/fimmu.2023.1290666","volume":"14","author":"H-P Hartung","year":"2023","unstructured":"Hartung, H.-P. et al. Bioavailable central nervous system disease-modifying therapies for multiple sclerosis. Front. Immunol. 14, 1290666 (2023).","journal-title":"Front. Immunol."},{"key":"1263_CR86","first-page":"369348","volume":"2015","author":"F Rinaldi","year":"2015","unstructured":"Rinaldi, F. et al. Disease-modifying drugs reduce cortical lesion accumulation and atrophy progression in relapsing-remitting multiple sclerosis: results from a 48-month extension study. Mult. Scler. Int. 2015, 369348 (2015).","journal-title":"Mult. Scler. Int."},{"key":"1263_CR87","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.msard.2018.11.009","volume":"27","author":"F Crescenzo","year":"2019","unstructured":"Crescenzo, F. et al. Effect of glatiramer acetate on cerebral grey matter pathology in patients with relapsing-remitting multiple sclerosis. Mult. Scler. Relat. Disord. 27, 305\u2013311 (2019).","journal-title":"Mult. Scler. Relat. Disord."},{"key":"1263_CR88","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1177\/13524585221104014","volume":"28","author":"D Marastoni","year":"2022","unstructured":"Marastoni, D. et al. Two years\u2019 effect of dimethyl fumarate on focal and diffuse gray matter pathology in multiple sclerosis. Mult. Scler. 28, 2090\u20132098 (2022).","journal-title":"Mult. Scler."},{"key":"1263_CR89","doi-asserted-by":"publisher","DOI":"10.1177\/1756286418805713","volume":"11","author":"M Puthenparampil","year":"2018","unstructured":"Puthenparampil, M. et al. NEDA-3 status including cortical lesions in the comparative evaluation of natalizumab versus fingolimod efficacy in multiple sclerosis. Ther. Adv. Neurol. Disord. 11, e1756286418805713 (2018).","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"1263_CR90","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1007\/s00415-023-12179-y","volume":"271","author":"A Bajrami","year":"2024","unstructured":"Bajrami, A. et al. Ocrelizumab reduces cortical and deep grey matter loss compared to the S1P-receptor modulator in multiple sclerosis. J. Neurol. 271, 2149\u20132158 (2024).","journal-title":"J. Neurol."},{"key":"1263_CR91","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1080\/14656566.2018.1434143","volume":"19","author":"M Pitteri","year":"2018","unstructured":"Pitteri, M., Magliozzi, R., Bajrami, A., Camera, V. & Calabrese, M. Potential neuroprotective effect of Fingolimod in multiple sclerosis and its association with clinical variables. Expert. Opin. Pharmacother. 19, 387\u2013395 (2018).","journal-title":"Expert. Opin. Pharmacother."},{"key":"1263_CR92","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/S0140-6736(18)30475-6","volume":"391","author":"L Kappos","year":"2018","unstructured":"Kappos, L. et al. Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study. Lancet 391, 1263\u20131273 (2018).","journal-title":"Lancet"},{"key":"1263_CR93","doi-asserted-by":"publisher","DOI":"10.1111\/jon.70032","volume":"35","author":"J Zurawski","year":"2025","unstructured":"Zurawski, J. et al. Cladribine is associated with stable cortical gray matter lesion burden in multiple sclerosis: a 7T MRI study. J. Neuroimaging 35, e70032 (2025).","journal-title":"J. Neuroimaging"},{"key":"1263_CR94","doi-asserted-by":"publisher","first-page":"uxae116","DOI":"10.1093\/cei\/uxae116","volume":"219","author":"K Allen-Philbey","year":"2025","unstructured":"Allen-Philbey, K. et al. Effects of cladribine on intrathecal and peripheral B and plasma cells. Clin. Exp. Immunol. 219, uxae116 (2025).","journal-title":"Clin. Exp. Immunol."},{"key":"1263_CR95","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-026-03725-2","volume":"23","author":"D Marastoni","year":"2026","unstructured":"Marastoni, D. et al. The effect of cladribine tablets on intrathecal inflammation in relapsing-remitting multiple sclerosis. J. Neuroinflammation 23, 92 (2026).","journal-title":"J. Neuroinflammation"},{"key":"1263_CR96","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0026712","volume":"6","author":"MP Sormani","year":"2011","unstructured":"Sormani, M. P. et al. Modeling the distribution of new MRI cortical lesions in multiple sclerosis longitudinal studies. PLoS ONE 6, e26712 (2011).","journal-title":"PLoS ONE"},{"key":"1263_CR97","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/ana.27270","volume":"98","author":"JJ Sabatino","year":"2025","unstructured":"Sabatino, J. J., Cree, B. A. C. & Hauser, S. L. New horizons for multiple sclerosis therapy: 2025 and Beyond. Ann. Neurol. 98, 317\u2013328 (2025).","journal-title":"Ann. Neurol."},{"key":"1263_CR98","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s00401-021-02293-4","volume":"141","author":"L van Olst","year":"2021","unstructured":"van Olst, L. et al. Meningeal inflammation in multiple sclerosis induces phenotypic changes in cortical microglia that differentially associate with neurodegeneration. Acta Neuropathol. 141, 881\u2013899 (2021).","journal-title":"Acta Neuropathol."},{"key":"1263_CR99","doi-asserted-by":"publisher","first-page":"4287","DOI":"10.1093\/brain\/awac232","volume":"145","author":"RE James Bates","year":"2022","unstructured":"James Bates, R. E. et al. Lymphotoxin-alpha expression in the meninges causes lymphoid tissue formation and neurodegeneration. Brain 145, 4287\u20134307 (2022).","journal-title":"Brain"},{"key":"1263_CR100","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.immuni.2015.11.010","volume":"43","author":"NB Pikor","year":"2015","unstructured":"Pikor, N. B. et al. Integration of TH17- and lymphotoxin-derived signals initiates meningeal-resident stromal cell remodeling to propagate neuroinflammation. Immunity 43, 1160\u20131173 (2015).","journal-title":"Immunity"},{"key":"1263_CR101","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1093\/cercor\/bhaa235","volume":"31","author":"M Donadieu","year":"2021","unstructured":"Donadieu, M. et al. Ultrahigh-resolution MRI reveals extensive cortical demyelination in a nonhuman primate model of multiple sclerosis. Cereb. Cortex 31, 439\u2013447 (2021).","journal-title":"Cereb. Cortex"},{"key":"1263_CR102","doi-asserted-by":"publisher","DOI":"10.1126\/science.adp6325","volume":"387","author":"J-P Lin","year":"2025","unstructured":"Lin, J.-P. et al. 4D marmoset brain map reveals MRI and molecular signatures for onset of multiple sclerosis\u2013like lesions. Science 387, eadp6325 (2025).","journal-title":"Science"},{"key":"1263_CR103","doi-asserted-by":"publisher","DOI":"10.1126\/science.adk4858","volume":"384","author":"A Shapson-Coe","year":"2024","unstructured":"Shapson-Coe, A. et al. A petavoxel fragment of human cerebral cortex reconstructed at nanoscale resolution. Science 384, eadk4858 (2024).","journal-title":"Science"},{"key":"1263_CR104","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1177\/1352458506070928","volume":"12","author":"C Laule","year":"2006","unstructured":"Laule, C. et al. Myelin water imaging in multiple sclerosis: quantitative correlations with histopathology. Mult. Scler. 12, 747\u2013753 (2006).","journal-title":"Mult. Scler."},{"key":"1263_CR105","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1093\/brain\/awab088","volume":"144","author":"R Rahmanzadeh","year":"2021","unstructured":"Rahmanzadeh, R. et al. Myelin and axon pathology in multiple sclerosis assessed by myelin water and multi-shell diffusion imaging. Brain 144, 1684\u20131696 (2021).","journal-title":"Brain"},{"key":"1263_CR106","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1002\/nbm.3486","volume":"29","author":"RM Gracien","year":"2016","unstructured":"Gracien, R. M. et al. Assessment of cortical damage in early multiple sclerosis with quantitative T2 relaxometry. NMR Biomed. 29, 444\u2013450 (2016).","journal-title":"NMR Biomed."},{"key":"1263_CR107","first-page":"742018","volume":"2012","author":"CL Tardif","year":"2012","unstructured":"Tardif, C. L., Bedell, B. J., Eskildsen, S. F., Collins, D. L. & Pike, G. B. Quantitative magnetic resonance imaging of cortical multiple sclerosis pathology. Mult. Scler. Int. 2012, 742018 (2012).","journal-title":"Mult. Scler. Int."},{"key":"1263_CR108","doi-asserted-by":"publisher","first-page":"789812","DOI":"10.3389\/fneur.2021.789812","volume":"12","author":"C Thaler","year":"2021","unstructured":"Thaler, C. et al. T1 relaxation times in the cortex and thalamus are associated with working memory and information processing speed in patients with multiple sclerosis. Front. Neurol. 12, 789812 (2021).","journal-title":"Front. Neurol."},{"key":"1263_CR109","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1177\/1352458519841810","volume":"26","author":"JWL Brown","year":"2020","unstructured":"Brown, J. W. L. et al. Magnetization transfer ratio abnormalities in primary and secondary progressive multiple sclerosis. Mult. Scler. 26, 679\u2013687 (2020).","journal-title":"Mult. Scler."},{"key":"1263_CR110","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1002\/hbm.22410","volume":"35","author":"M Derakhshan","year":"2014","unstructured":"Derakhshan, M., Caramanos, Z., Narayanan, S., Arnold, D. L. & Louis Collins, D. Surface-based analysis reveals regions of reduced cortical magnetization transfer ratio in patients with multiple sclerosis: a proposed method for imaging subpial demyelination. Hum. Brain Mapp. 35, 3402\u20133413 (2014).","journal-title":"Hum. Brain Mapp."},{"key":"1263_CR111","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.nicl.2016.10.010","volume":"12","author":"DA Rudko","year":"2016","unstructured":"Rudko, D. A. et al. Delineation of cortical pathology in multiple sclerosis using multi-surface magnetization transfer ratio imaging. NeuroImage Clin. 12, 858\u2013868 (2016).","journal-title":"NeuroImage Clin."},{"key":"1263_CR112","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1136\/jnnp-2021-327803","volume":"93","author":"P Preziosa","year":"2022","unstructured":"Preziosa, P. et al. In vivo detection of damage in multiple sclerosis cortex and cortical lesions using NODDI. J. Neurol. Neurosurg. Psychiatry 93, 628\u2013636 (2022). Preziosa et al. demonstrated that NODDI-based diffusion MRI enables in vivo detection of microstructural damage in the cortex and cortical lesions of people with MS, providing sensitive markers of cortical pathology beyond conventional MRI.","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1263_CR113","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00415-022-11386-3","volume":"270","author":"M Margoni","year":"2023","unstructured":"Margoni, M. et al. In vivo quantification of brain soma and neurite density abnormalities in multiple sclerosis. J. Neurol. 270, 433\u2013445 (2023).","journal-title":"J. Neurol."},{"key":"1263_CR114","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-60497-6","volume":"14","author":"M Barakovic","year":"2024","unstructured":"Barakovic, M. et al. A novel imaging marker of cortical \u2018cellularity\u2019 in multiple sclerosis patients. Sci. Rep. 14, 9848 (2024).","journal-title":"Sci. Rep."},{"key":"1263_CR115","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209604","volume":"103","author":"J M\u00fcller","year":"2024","unstructured":"M\u00fcller, J. et al. Quantifying remyelination using \u03c7-separation in white matter and cortical multiple sclerosis lesions. Neurology 103, e209604 (2024).","journal-title":"Neurology"},{"key":"1263_CR116","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000207966","volume":"102","author":"R Galbusera","year":"2024","unstructured":"Galbusera, R. et al. Characteristics, prevalence, and clinical relevance of juxtacortical paramagnetic rims in patients with multiple sclerosis. Neurology 102, e207966 (2024).","journal-title":"Neurology"},{"key":"1263_CR117","doi-asserted-by":"publisher","first-page":"e2965","DOI":"10.1212\/WNL.0000000000010909","volume":"95","author":"M Moccia","year":"2020","unstructured":"Moccia, M. et al. Pathologic correlates of the magnetization transfer ratio in multiple sclerosis. Neurology 95, e2965\u2013e2976 (2020).","journal-title":"Neurology"},{"key":"1263_CR118","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/ana.25197","volume":"83","author":"R Magliozzi","year":"2018","unstructured":"Magliozzi, R. et al. Inflammatory intrathecal profiles and cortical damage in multiple sclerosis. Ann. Neurol. 83, 739\u2013755 (2018). Seminal evidence linking intrathecal inflammatory profiles to cortical damage in multiple sclerosis, establishing compartmentalized inflammation as a key driver of grey matter pathology.","journal-title":"Ann. Neurol."},{"key":"1263_CR119","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001083","volume":"8","author":"D Marastoni","year":"2021","unstructured":"Marastoni, D. et al. CSF Levels of CXCL12 and osteopontin as early markers of primary progressive multiple sclerosis. Neurol. Neuroimmunol. Neuroinflamm. 8, e1083 (2021).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"1263_CR120","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/nrn3900","volume":"16","author":"M Calabrese","year":"2015","unstructured":"Calabrese, M. et al. Exploring the origins of grey matter damage in multiple sclerosis. Nat. Rev. Neurosci. 16, 147\u2013158 (2015). A comprehensive and authoritative review of the mechanisms underlying grey matter damage and cortical lesion formation in MS, integrating pathological, immunological and imaging evidence.","journal-title":"Nat. Rev. Neurosci."},{"key":"1263_CR121","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200265","volume":"11","author":"D Marastoni","year":"2024","unstructured":"Marastoni, D. et al. Association of levels of CSF osteopontin with cortical atrophy and disability in early multiple sclerosis. Neurol. Neuroimmunol. Neuroinflamm. 11, e200265 (2024).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"1263_CR122","doi-asserted-by":"publisher","first-page":"554803","DOI":"10.3389\/fneur.2020.00973","volume":"11","author":"RA Todea","year":"2020","unstructured":"Todea, R. A. et al. Evolution of cortical and white matter lesion load in early-stage multiple sclerosis: correlation with neuroaxonal damage and clinical changes. Front. Neurol. 11, 554803 (2020).","journal-title":"Front. Neurol."},{"key":"1263_CR123","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-95229-x","volume":"15","author":"A Miclea","year":"2025","unstructured":"Miclea, A. et al. Novel serum biomarker associations with 7 Tesla MRI-defined cortical lesions, leptomeningeal enhancement, and deep gray matter volume in early multiple sclerosis. Sci. Rep. 15, 12032 (2025).","journal-title":"Sci. Rep."},{"key":"1263_CR124","doi-asserted-by":"publisher","DOI":"10.1002\/nbm.4730","volume":"35","author":"F La Rosa","year":"2022","unstructured":"La Rosa, F. et al. Multiple sclerosis cortical lesion detection with deep learning at ultra-high-field MRI. NMR Biomed. 35, e4730 (2022).","journal-title":"NMR Biomed."},{"key":"1263_CR125","doi-asserted-by":"publisher","first-page":"103818","DOI":"10.1016\/j.nicl.2025.103818","volume":"48","author":"PM Gordaliza","year":"2025","unstructured":"Gordaliza, P. M. et al. Fluid and white matter suppression contrasts MRI improves deep learning detection of multiple sclerosis cortical lesions. NeuroImage Clin. 48, 103818 (2025).","journal-title":"NeuroImage Clin."},{"key":"1263_CR126","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1007\/s00330-024-11157-w","volume":"35","author":"Z Zhuo","year":"2025","unstructured":"Zhuo, Z. et al. Spatial structural abnormality maps associated with cognitive and physical performance in relapsing-remitting multiple sclerosis. Eur. Radiol. 35, 1228\u20131241 (2025).","journal-title":"Eur. Radiol."},{"key":"1263_CR127","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.3174\/ajnr.A4485","volume":"36","author":"D Pareto","year":"2015","unstructured":"Pareto, D. et al. Juxtacortical lesions and cortical thinning in multiple sclerosis. AJNR Am. J. Neuroradiol. 36, 2270\u20132276 (2015).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"1263_CR128","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1007\/s00415-021-10400-4","volume":"268","author":"CA Treaba","year":"2021","unstructured":"Treaba, C. A. et al. The relevance of multiple sclerosis cortical lesions on cortical thinning and their clinical impact as assessed by 7.0-T MRI. J. Neurol. 268, 2473\u20132481 (2021). Treaba et al. demonstrated that cortical lesion burden is a key determinant of cortical atrophy, supporting a direct link between focal cortical pathology and grey matter loss in MS.","journal-title":"J. Neurol."},{"key":"1263_CR129","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1093\/brain\/awl135","volume":"129","author":"D Merkler","year":"2006","unstructured":"Merkler, D., Ernsting, T., Kerschensteiner, M., Br\u00fcck, W. & Stadelmann, C. A new focal EAE model of cortical demyelination: multiple sclerosis-like lesions with rapid resolution of inflammation and extensive remyelination. Brain 129, 1972\u20131983 (2006).","journal-title":"Brain"},{"key":"1263_CR130","doi-asserted-by":"publisher","first-page":"117538","DOI":"10.1016\/j.celrep.2026.117538","volume":"45","author":"AMR van den Bosch","year":"2026","unstructured":"van den Bosch, A. M. R. et al. Microglial states associate with lesion dynamics in multiple sclerosis. Cell Rep. 45, 117538 (2026).","journal-title":"Cell Rep."},{"key":"1263_CR131","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.neuroimage.2008.06.028","volume":"42","author":"M Calabrese","year":"2008","unstructured":"Calabrese, M. et al. Morphology and evolution of cortical lesions in multiple sclerosis. A longitudinal MRI study. NeuroImage 42, 1324\u20131328 (2008).","journal-title":"NeuroImage"},{"key":"1263_CR132","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1177\/1352458508096686","volume":"15","author":"M Calabrese","year":"2009","unstructured":"Calabrese, M. et al. Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study. Mult. Scler. 15, 36\u201341 (2009).","journal-title":"Mult. Scler."},{"key":"1263_CR133","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1177\/1352458509102907","volume":"15","author":"SD Roosendaal","year":"2009","unstructured":"Roosendaal, S. D. et al. Accumulation of cortical lesions in MS: relation with cognitive impairment. Mult. Scler. 15, 708\u2013714 (2009). Early in vivo evidence linking the accumulation of cortical lesions to cognitive impairment in MS.","journal-title":"Mult. Scler."},{"key":"1263_CR134","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1136\/jnnp.2009.177733","volume":"81","author":"M Calabrese","year":"2010","unstructured":"Calabrese, M. et al. Magnetic resonance evidence of cerebellar cortical pathology in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 81, 401\u2013404 (2010).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1263_CR135","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/ana.21906","volume":"67","author":"M Calabrese","year":"2010","unstructured":"Calabrese, M. et al. A 3-year magnetic resonance imaging study of cortical lesions in relapse-onset multiple sclerosis. Ann. Neurol. 67, 376\u2013383 (2010).","journal-title":"Ann. Neurol."},{"key":"1263_CR136","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1177\/1352458511418550","volume":"18","author":"M Calabrese","year":"2012","unstructured":"Calabrese, M. et al. The association of intrathecal immunoglobulin synthesis and cortical lesions predicts disease activity in clinically isolated syndrome and early relapsing\u2013remitting multiple sclerosis. Mult. Scler. 18, 174\u2013180 (2012).","journal-title":"Mult. Scler."},{"key":"1263_CR137","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1093\/brain\/aws246","volume":"135","author":"M Calabrese","year":"2012","unstructured":"Calabrese, M. et al. Cortical lesion load associates with progression of disability in multiple sclerosis. Brain 135, 2952\u20132961 (2012).","journal-title":"Brain"},{"key":"1263_CR138","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/ana.23882","volume":"74","author":"M Calabrese","year":"2013","unstructured":"Calabrese, M. et al. The changing clinical course of multiple sclerosis: a matter of gray matter. Ann. Neurol. 74, 76\u201383 (2013).","journal-title":"Ann. Neurol."},{"key":"1263_CR139","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1177\/1352458512463767","volume":"19","author":"M Calabrese","year":"2013","unstructured":"Calabrese, M. et al. Low degree of cortical pathology is associated with benign course of multiple sclerosis. Mult. Scler. 19, 904\u2013911 (2013).","journal-title":"Mult. Scler."},{"key":"1263_CR140","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1177\/1352458514558134","volume":"21","author":"DM Harrison","year":"2015","unstructured":"Harrison, D. M. et al. Thalamic lesions in multiple sclerosis by 7T MRI: clinical implications and relationship to cortical pathology. Mult. Scler. 21, 1139\u20131150 (2015).","journal-title":"Mult. Scler."},{"key":"1263_CR141","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1177\/1352458519867320","volume":"26","author":"E Herranz","year":"2020","unstructured":"Herranz, E. et al. Profiles of cortical inflammation in multiple sclerosis by 11C-PBR28 MR-PET and 7 Tesla imaging. Mult. Scler. 26, 1497\u20131509 (2020).","journal-title":"Mult. Scler."},{"key":"1263_CR142","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1111\/ene.14859","volume":"28","author":"AI Pisani","year":"2021","unstructured":"Pisani, A. I., Scalfari, A., Crescenzo, F., Romualdi, C. & Calabrese, M. A novel prognostic score to assess the risk of progression in relapsing-remitting multiple sclerosis patients. Eur. J. Neurol. 28, 2503\u20132512 (2021).","journal-title":"Eur. J. Neurol."},{"key":"1263_CR143","doi-asserted-by":"publisher","first-page":"fcab134","DOI":"10.1093\/braincomms\/fcab134","volume":"3","author":"CA Treaba","year":"2021","unstructured":"Treaba, C. A. et al. Cortical and phase rim lesions on 7 T MRI as markers of multiple sclerosis disease progression. Brain Commun. 3, fcab134 (2021).","journal-title":"Brain Commun."},{"key":"1263_CR144","doi-asserted-by":"publisher","first-page":"6702","DOI":"10.1007\/s00415-024-12622-8","volume":"271","author":"A Miscioscia","year":"2024","unstructured":"Miscioscia, A. et al. The contribution of paramagnetic rim and cortical lesions to physical and cognitive disability at multiple sclerosis clinical onset: evaluating the power of MRI and OCT biomarkers. J. Neurol. 271, 6702\u20136714 (2024).","journal-title":"J. Neurol."},{"key":"1263_CR145","doi-asserted-by":"publisher","first-page":"fcag059","DOI":"10.1093\/braincomms\/fcag059","volume":"8","author":"A Miscioscia","year":"2026","unstructured":"Miscioscia, A. et al. Spinal cord versus brain imaging biomarkers of multiple sclerosis trajectory combining 7T and 3T MRI. Brain Commun. 8, fcag059 (2026).","journal-title":"Brain Commun."}],"container-title":["Nature Reviews Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41582-026-01263-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41582-026-01263-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41582-026-01263-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:01:31Z","timestamp":1793192491000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41582-026-01263-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,7]]},"references-count":145,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["1263"],"URL":"https:\/\/doi.org\/10.1038\/s41582-026-01263-2","relation":{},"ISSN":["1759-4758","1759-4766"],"issn-type":[{"value":"1759-4758","type":"print"},{"value":"1759-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,7]]},"assertion":[{"value":"20 August 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}